Actively Recruiting
Role of Exosomes in Pancreatic Cancer Progression
Led by IRCCS Azienda Ospedaliero-Universitaria di Bologna · Updated on 2025-01-15
60
Participants Needed
1
Research Sites
257 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The present pilot study is set up with the objective of identifying circulating markers in the biological fluids (blood and urine) of subjects with pancreatic carcinoma and their association with disease stage, to evaluate their potential use as predictive and diagnostic markers for this tumor of difficult early diagnosis and often inauspicious prognosis.
CONDITIONS
Official Title
Role of Exosomes in Pancreatic Cancer Progression
Who Can Participate
Eligibility Criteria
You may qualify if you...
- People with pancreatic cancer
- 18 years old
- Obtaining informed consent.
You will not qualify if you...
- Patients who do not need or cannot perform endoscopy with biopsy sampling
- Patients with a previous or active cancer other than pancreatic cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Bologna, Italy, 40138
Actively Recruiting
Research Team
L
Leonardo Henry Umberto Eusebi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here